METHOD OF MEDICALLY INDUCED SUPPORT OF PATIENTS DURING IMPLEMENTATION OF OSTEOPLASTIC OPERATIONS Russian patent published in 2017 - IPC A61B17/04 A61N5/06 A61K31/17 A61K31/18 A61K31/41 A61K31/495 A61K31/52 A61K31/7048 A61K33/06 A61K35/14 A61K38/39 A61K38/41 A61P1/02 

FIELD: medicine.

SUBSTANCE: seven days prior to the operation and within three weeks after the operation, the patient is administered the drug Trental in tablets at a dose of 100 to 400 mg and the drug Actovegin by 1 pill up to three times a day. As an antibacterial agent on the day of the operation and within six days after it, Klacid SR is administered at a dose of 500 mg by 1 tablet 2 times a day. From the first day after the operation until the removal of the sutures, Zyrtec is administered at a dose of 10 mg by 1 tablet per day. For anesthesia, the patient is administered a selective COX-2 inhibitor by 1 tablet after a meal. From the first day after the operation until the removal of the sutures, PerioKin gel is topically applied to the patient's surgery area 2-3 times a day. Within three weeks after the operation, ultraviolet gum irradiation and local laser therapy are performed, alternating these physiotherapeutic procedures daily. From the third day after the operation, paste and rinse after toothbrushing KIN® GINGIVAL ALPHANTA are used 2-3 times a day after a meal. 3 weeks after the operation Osteogenon drug is administered by 1 tablet twice a day and Chlorophyll Forte GP drug is administered by 1 capsule 1 time per day.

EFFECT: improvement of microcirculation and trophism of tissues in the operated zone, creation of optimal conditions for reparative osteogenesis in the field of plastic and wound healing, prevention of postoperative complications concerning soft tissues.

1 ex